StonvexLoading…
StonvexStonvexStonvexCore line items from CRNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $251.78M | $331.50M | $294.48M | $327.89M |
Operating Income | $-2.29M | $-579.94M | $-27.20M | $-184.34M |
Net Income | $-18.71M | $-588.08M | $-56.25M | $-310.83M |
EPS (Diluted) | $-0.43 | $-14.12 | $-1.40 | $-7.93 |
Total Assets | $630.59M | $702.36M | $1.30B | $1.32B |
Total Liabilities | $479.92M | $561.26M | $602.72M | $605.54M |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $46.82M | $12.20M | $2.37M | $-19.58M |
Shares Outstanding | 43.37M | 41.92M | 40.42M | 39.43M |